Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06116292

Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma Using the ESTOI Mobile Application

Led by Hospital Universitari de Bellvitge · Updated on 2024-10-22

108

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Asthma is a common and chronic lung condition that can be challenging to control in severe cases. This research aims to evaluate the effect of using a mobile application called ESTOI on asthma control, treatment adherence, and quality of life over a 52-week period. The study involves adults diagnosed with asthma and is conducted at a specialized hospital in Spain, focusing on improving disease management through digital support. Participants will be randomly assigned to one of two groups. The intervention group will receive standard care plus access to the ESTOI app, which offers symptom tracking, personalized treatment information, peak flow recording, nutritional guidance, and messaging with healthcare providers. The control group will receive usual care and asthma education without app access. Both groups will use a Peak Flow Meter and follow a schedule of three visits across the year. During the study visits, participants will complete questionnaires assessing asthma control, inhaler use, quality of life, and anxiety or depression. They will undergo lung function tests, blood tests, and exhaled nitric oxide measurements. Data on medication use and asthma exacerbations will be collected and monitored. The study will analyze these outcomes to understand how the app influences asthma management and patient wellbeing over one year.

CONDITIONS

Brief Title

Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older with a diagnosis of asthma based on GEMA 5.2 2022
  • Patients receiving care at the pulmonology service of the study center
  • Patients who have not previously received asthma education
  • Able to provide signed informed consent
Not Eligible

You will not qualify if you...

  • No access to a mobile device with Android or iOS
  • Lack of minimum technological knowledge to use the ESTOI application
  • Participation in a clinical trial within the last 6 months
  • Diagnosis of other respiratory diseases except obstructive sleep apnea or Asthma-COPD overlap syndrome
  • Presence of palliative or severe chronic illnesses limiting life expectancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 52 weeks

Participants are introduced to the ESTOI mobile application and provided with asthma education, a Peakflow meter, and instructions for use. Those in the control group receive standard care and health education.

3 visits at weeks 0, 26, and 52 (in-person)

Trial Site Locations

Total: 1 location

1

Bellvitge University Hospital

Barcelona, Barcelona, Spain, 08907

Actively Recruiting

Loading map...

Research Team

H

Héctor Cabrerizo Carreño, M.N

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

GBD 2015 Chronic Respiratory Disease Collaborators

https://pubmed.ncbi.nlm.nih.gov/28822787

Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys.

Klaus F Rabe, Mitsuru Adachi, Christopher K W Lai...

https://pubmed.ncbi.nlm.nih.gov/15241342

[Multidisciplinary Consensus for the Monitoring and Control of Asthma Through Telemedicine. The COMETA Project].

Carlos Almonacid Sánchez, Marina Blanco Aparicio, Javier Domínguez Ortega...

https://pubmed.ncbi.nlm.nih.gov/37497073

Understanding clinicians' attitudes toward a mobile health strategy to childhood asthma management: A qualitative study.

Jessica P Hollenbach, Anna Cushing, Emilie Melvin...

https://pubmed.ncbi.nlm.nih.gov/27880049

The efficacy of a mobile phone application to improve adherence to treatment and self-management in people with chronic respiratory disease in Romanian population - a pilot study.

Laura Adela Munteanu, Mirela Frandes, Bogdan Timar...

https://pubmed.ncbi.nlm.nih.gov/32460752

Enhancing Asthma Patients' Self-Management through Smartphone-Based Application: Design, Usability Evaluation, and Educational Intervention.

Mehrdad Farzandipour, Ehsan Nabovati, Marzieh Heidarzadeh Arani...

https://pubmed.ncbi.nlm.nih.gov/31724144